Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat-dose placebo-controlled ascending study of GSK356278 in healthy volunteers
NL-OMON35301Active, not recruiting
- Sponsor
- GSK
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of gsk356278 in Huntington disease (HD) (6 cohorts), sponsored by GSK. Primary endpoints: Pharmaco-EEG metrics, Cognitive tests and 11 more. Started Dec 2011; status: active, not recruiting.
02
Drugs
gsk356278
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NL-OMON35301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35301.